Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. pediatric research 
3. review 
4. article
Show authors
•  Review
•  Published: 28 October 2013


Emerging role of autophagy in
pediatric neurodegenerative
and neurometabolic diseases
•  Darius Ebrahimi-Fakhari
1,2,
•  Lara Wahlster1,3,
•  Georg F. Hoffmann1 &
•  …
•  Stefan Kölker1 
Pediatric Research volume 75, pages 217–226 (2014)Cite this article
•  5892 Accesses
•  48 Citations
•  Metrics details
Subjects
•  Autophagy
•  Metabolic diseases
•  Neurodegenerative diseases
•  Paediatrics
A Corrigendum to this article was published on 26 August 2014
This article has been updated
Abstract
Pediatric neurodegenerative diseases are a heterogeneous group of


diseases that result from specific genetic and biochemical defects. In
recent years, studies have revealed a wide spectrum of abnormal
cellular functions that include impaired proteolysis, abnormal lipid
trafficking, accumulation of lysosomal content, and mitochondrial
dysfunction. Within neurons, elaborated degradation pathways such
as the ubiquitin–proteasome system and the autophagy–lysosomal
pathway are critical for maintaining homeostasis and normal cell
function. Recent evidence suggests a pivotal role for autophagy in
major adult and pediatric neurodegenerative diseases. We herein
review genetic, pathological, and molecular evidence for the
emerging link between autophagy dysfunction and lysosomal
storage disorders such as Niemann–Pick type C, progressive
myoclonic epilepsies such as Lafora disease, and leukodystrophies
such as Alexander disease. We also discuss the recent discovery of
genetically deranged autophagy in Vici syndrome, a multisystem
disorder, and the implications for the role of autophagy in
development and disease. Deciphering the exact mechanism by
which autophagy contributes to disease pathology may open novel
therapeutic avenues to treat neurodegeneration. To this end, an
outlook on novel therapeutic approaches targeting autophagy
concludes this review.
Similar content being viewed by others
[image]
Mechanisms of autophagy–lysosome dysfunction in
neurodegenerative diseases
Article 06 August 2024
[image]
Epigenetic and post-translational modifications in
autophagy: biological functions and therapeutic
targets
Article Open access 16 January 2023
[image]


Autophagy regulation by acetylation—implications
for neurodegenerative diseases
Article Open access 22 January 2021
Log in or create a free account to read this
content
Gain free access to this article, as well as selected content from this
journal and more on nature.com
 Access through your institution
or
 Sign in or create an account 
[image] Continue with Google 
[image] Continue with ORCiD 
Change history
•  
26 August 2014
Darius Ebrahimi-Fakhari, Lara Wahlster, Georg F. Hoffmann
and Stefan Kölker Pediatr Res 75:217–226 (2014);
doi:10.1038/pr.2013.185 In the published Figure 7, the labels
for two signaling molecules—RHEB and TSC1-TSC2—were
transposed. The corrected figure is shown below.
References
1. Ebrahimi-Fakhari D, Wahlster L, McLean PJ . Protein
degradation pathways in Parkinson’s disease: curse or


blessing. Acta Neuropathol 2012;124:153–72.
Article  CAS  Google Scholar 
2. Ihara Y, Morishima-Kawashima M, Nixon R . The ubiquitin-
proteasome system and the autophagic-lysosomal system in
Alzheimer disease. Cold Spring Harb Perspect Med 2012;2.
3. Ebrahimi-Fakhari D, Wahlster L, McLean PJ . Molecular
chaperones in Parkinson’s disease–present and future. J
Parkinsons Dis 2011;1:299–320.
CAS  PubMed  PubMed Central  Google Scholar 
4. Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S,
Walkley SU, Ballabio A . Autophagy in lysosomal storage
disorders. Autophagy 2012;8:719–30.
Article  CAS  Google Scholar 
5. Mizushima N, Komatsu M . Autophagy: renovation of cells
and tissues. Cell 2011;147:728–41.
Article  CAS  Google Scholar 
6. Behrends C, Sowa ME, Gygi SP, Harper JW . Network
organization of the human autophagy system. Nature
2010;466:68–76.
Article  CAS  Google Scholar 
7. Mizushima N, Yoshimori T, Ohsumi Y . The role of Atg
proteins in autophagosome formation. Annu Rev Cell Dev Biol
2011;27:107–32.
Article  CAS  Google Scholar 
8. Settembre C, Di Malta C, Polito VA, et al. TFEB links
autophagy to lysosomal biogenesis. Science 2011;332:1429–
33.
Article  CAS  Google Scholar 


9. Sardiello M, Palmieri M, di Ronza A, et al. A gene network
regulating lysosomal biogenesis and function. Science
2009;325:473–7.
Article  CAS  Google Scholar 
10. Funderburk SF, Wang QJ, Yue Z . The Beclin 1-VPS34
complex–at the crossroads of autophagy and beyond. Trends
Cell Biol 2010;20:355–62.
Article  CAS  Google Scholar 
11. Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for
the use and interpretation of assays for monitoring
autophagy. Autophagy 2012;8:445–544.
Article  CAS  Google Scholar 
12. Jahreiss L, Menzies FM, Rubinsztein DC . The itinerary of
autophagosomes: from peripheral formation to kiss-and-run
fusion with lysosomes. Traffic 2008;9:574–87.
Article  CAS  Google Scholar 
13. Ashrafi G, Schwarz TL . The pathways of mitophagy for
quality control and clearance of mitochondria. Cell Death
Differ 2013;20:31–42.
Article  CAS  Google Scholar 
14. Ebrahimi-Fakhari D, McLean PJ, Unni VK . Alpha-synuclein’s
degradation in vivo: opening a new (cranial) window on the
roles of degradation pathways in Parkinson disease.
Autophagy 2012;8:281–3.
Article  CAS  Google Scholar 
15. Cook C, Stetler C, Petrucelli L . Disruption of protein quality
control in Parkinson’s disease. Cold Spring Harb Perspect Med
2012;2:a009423.
Article  Google Scholar 


16. Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, et al.
Distinct roles in vivo for the ubiquitin-proteasome system and
the autophagy-lysosomal pathway in the degradation of a-
synuclein. J Neurosci 2011;31:14508–20.
Article  CAS  Google Scholar 
17. Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1
disease gene: homology to mediators of cholesterol
homeostasis. Science 1997;277:228–31.
Article  CAS  Google Scholar 
18. Naureckiene S, Sleat DE, Lackland H, et al. Identification of
HE1 as the second gene of Niemann-Pick C disease. Science
2000;290:2298–301.
Article  CAS  Google Scholar 
19. Schulze H, Sandhoff K . Lysosomal lipid storage diseases. Cold
Spring Harb Perspect Biol 2011;3.
20. Vance JE, Peake KB . Function of the Niemann-Pick type C
proteins and their bypass by cyclodextrin. Curr Opin Lipidol
2011;22:204–9.
Article  CAS  Google Scholar 
21. Ko DC, Milenkovic L, Beier SM, Manuel H, Buchanan J, Scott
MP . Cell-autonomous death of cerebellar purkinje neurons
with autophagy in Niemann-Pick type C disease. PLoS Genet
2005;1:81–95.
Article  CAS  Google Scholar 
22. Liao G, Yao Y, Liu J, et al. Cholesterol accumulation is
associated with lysosomal dysfunction and autophagic stress
in Npc1 -/- mouse brain. Am J Pathol 2007;171:962–75.
Article  CAS  Google Scholar 
23. Pacheco CD, Kunkel R, Lieberman AP . Autophagy in


Niemann-Pick C disease is dependent upon Beclin-1 and
responsive to lipid trafficking defects. Hum Mol Genet
2007;16:1495–503.
Article  CAS  Google Scholar 
24. Ishibashi S, Yamazaki T, Okamoto K . Association of
autophagy with cholesterol-accumulated compartments in
Niemann-Pick disease type C cells. J Clin Neurosci
2009;16:954–9.
Article  CAS  Google Scholar 
25. Pacheco CD, Elrick MJ, Lieberman AP . Tau deletion
exacerbates the phenotype of Niemann-Pick type C mice and
implicates autophagy in pathogenesis. Hum Mol Genet
2009;18:956–65.
Article  CAS  Google Scholar 
26. Ordonez MP, Roberts EA, Kidwell CU, Yuan SH, Plaisted WC,
Goldstein LS . Disruption and therapeutic rescue of autophagy
in a human neuronal model of Niemann Pick type C1. Hum
Mol Genet 2012;21:2651–62.
Article  CAS  Google Scholar 
27. Elrick MJ, Yu T, Chung C, Lieberman AP . Impaired
proteolysis underlies autophagic dysfunction in Niemann-Pick
type C disease. Hum Mol Genet 2012;21:4876–87.
Article  CAS  Google Scholar 
28. Amritraj A, Wang Y, Revett TJ, Vergote D, Westaway D, Kar S
. Role of cathepsin D in U18666A-induced neuronal cell
death: potential implication in Niemann-Pick type C disease
pathogenesis. J Biol Chem 2013;288:3136–52.
Article  CAS  Google Scholar 
29. Dionisi Vici C, Sabetta G, Gambarara M, et al. Agenesis of the
corpus callosum, combined immunodeficiency, bilateral


cataract, and hypopigmentation in two brothers. Am J Med
Genet 1988;29:1–8.
Article  CAS  Google Scholar 
30. McClelland V, Cullup T, Bodi I, et al. Vici syndrome
associated with sensorineural hearing loss and evidence of
neuromuscular involvement on muscle biopsy. Am J Med
Genet A 2010;152A:741–7.
Article  Google Scholar 
31. Cullup T, Kho AL, Dionisi-Vici C, et al. Recessive mutations in
EPG5 cause Vici syndrome, a multisystem disorder with
defective autophagy. Nat Genet 2013;45:83–7.
Article  CAS  Google Scholar 
32. Al-Owain M, Al-Hashem A, Al-Muhaizea M, et al. Vici
syndrome associated with unilateral lung hypoplasia and
myopathy. Am J Med Genet A 2010;152A:1849–53.
Article  Google Scholar 
33. Tian Y, Li Z, Hu W, et al. C. elegans screen identifies
autophagy genes specific to multicellular organisms. Cell
2010;141:1042–55.
Article  CAS  Google Scholar 
34. Halama N, Grauling-Halama SA, Beder A, Jäger D .
Comparative integromics on the breast cancer-associated gene
KIAA1632: clues to a cancer antigen domain. Int J Oncol
2007;31:205–10.
CAS  PubMed  Google Scholar 
35. Tan JM, Wong ES, Kirkpatrick DS, et al. Lysine 63-linked
ubiquitination promotes the formation and autophagic
clearance of protein inclusions associated with
neurodegenerative diseases. Hum Mol Genet 2008;17:431–9.


Article  CAS  Google Scholar 
36. Vázquez P, Arroba AI, Cecconi F, de la Rosa EJ, Boya P, de
Pablo F . Atg5 and Ambra1 differentially modulate
neurogenesis in neural stem cells. Autophagy 2012;8:187–99.
Article  Google Scholar 
37. Fimia GM, Stoykova A, Romagnoli A, et al. Ambra1 regulates
autophagy and development of the nervous system. Nature
2007;447:1121–5.
Article  CAS  Google Scholar 
38. Kuma A, Hatano M, Matsui M, et al. The role of autophagy
during the early neonatal starvation period. Nature
2004;432:1032–6.
Article  CAS  Google Scholar 
39. Hara T, Nakamura K, Matsui M, et al. Suppression of basal
autophagy in neural cells causes neurodegenerative disease in
mice. Nature 2006;441:885–9.
Article  CAS  Google Scholar 
40. Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the
central nervous system causes neurodegeneration in mice.
Nature 2006;441:880–4.
Article  CAS  Google Scholar 
41. Zhao H, Zhao YG, Wang X, et al. Mice deficient in Epg5
exhibit selective neuronal vulnerability to degeneration. J Cell
Biol 2013;200:731–41.
Article  CAS  Google Scholar 
42. Yokoi S, Nakayama H, Negishi T . Biochemical studies on
tissues from a patient with Lafora disease. Clin Chim Acta
1975;62:415–23.


Article  CAS  Google Scholar 
43. Manetto V, Abdul-Karim FW, Perry G, Tabaton M, Autilio-
Gambetti L, Gambetti P . Selective presence of ubiquitin in
intracellular inclusions. Am J Pathol 1989;134:505–13.
CAS  PubMed  PubMed Central  Google Scholar 
44. Ganesh S, Delgado-Escueta AV, Sakamoto T, et al. Targeted
disruption of the Epm2a gene causes formation of Lafora
inclusion bodies, neurodegeneration, ataxia, myoclonus
epilepsy and impaired behavioral response in mice. Hum Mol
Genet 2002;11:1251–62.
Article  CAS  Google Scholar 
45. Minassian BA, Lee JR, Herbrick JA, et al. Mutations in a gene
encoding a novel protein tyrosine phosphatase cause
progressive myoclonus epilepsy. Nat Genet 1998;20:171–4.
Article  CAS  Google Scholar 
46. Chan EM, Young EJ, Ianzano L, et al. Mutations in NHLRC1
cause progressive myoclonus epilepsy. Nat Genet
2003;35:125–7.
Article  CAS  Google Scholar 
47. Gentry MS, Romá-Mateo C, Sanz P . Laforin, a protein with
many faces: glucan phosphatase, adapter protein, et alii. FEBS
J 2013;280:525–37.
Article  CAS  Google Scholar 
48. Gentry MS, Worby CA, Dixon JE . Insights into Lafora disease:
malin is an E3 ubiquitin ligase that ubiquitinates and
promotes the degradation of laforin. Proc Natl Acad Sci USA
2005;102:8501–6.
Article  CAS  Google Scholar 
49. Turnbull J, Girard JM, Lohi H, et al. Early-onset Lafora body


disease. Brain 2012;135(Pt 9):2684–98.
Article  Google Scholar 
50. Tagliabracci VS, Turnbull J, Wang W, et al. Laforin is a
glycogen phosphatase, deficiency of which leads to elevated
phosphorylation of glycogen in vivo. Proc Natl Acad Sci USA
2007;104:19262–6.
Article  CAS  Google Scholar 
51. Tagliabracci VS, Heiss C, Karthik C, et al. Phosphate
incorporation during glycogen synthesis and Lafora disease.
Cell Metab 2011;13:274–82.
Article  CAS  Google Scholar 
52. Worby CA, Gentry MS, Dixon JE . Laforin, a dual specificity
phosphatase that dephosphorylates complex carbohydrates. J
Biol Chem 2006;281:30412–8.
Article  CAS  Google Scholar 
53. Vernia S, Rubio T, Heredia M, Rodríguez de Córdoba S, Sanz
P . Increased endoplasmic reticulum stress and decreased
proteasomal function in lafora disease models lacking the
phosphatase laforin. PLoS ONE 2009;4:e5907.
Article  Google Scholar 
54. Mittal S, Dubey D, Yamakawa K, Ganesh S . Lafora disease
proteins malin and laforin are recruited to aggresomes in
response to proteasomal impairment. Hum Mol Genet
2007;16:753–62.
Article  CAS  Google Scholar 
55. Puri R, Suzuki T, Yamakawa K, Ganesh S . Dysfunctions in
endosomal-lysosomal and autophagy pathways underlie
neuropathology in a mouse model for Lafora disease. Hum
Mol Genet 2012;21:175–84.


Article  Google Scholar 
56. Garyali P, Siwach P, Singh PK, et al. The malin-laforin
complex suppresses the cellular toxicity of misfolded proteins
by promoting their degradation through the ubiquitin-
proteasome system. Hum Mol Genet 2009;18:688–700.
Article  CAS  Google Scholar 
57. Rao SN, Sharma J, Maity R, Jana NR . Co-chaperone CHIP
stabilizes aggregate-prone malin, a ubiquitin ligase mutated
in Lafora disease. J Biol Chem 2010;285:1404–13.
Article  CAS  Google Scholar 
58. Sengupta S, Badhwar I, Upadhyay M, Singh S, Ganesh S .
Malin and laforin are essential components of a protein
complex that protects cells from thermal stress. J Cell Sci
2011;124(Pt 13):2277–86.
Article  CAS  Google Scholar 
59. Aguado C, Sarkar S, Korolchuk VI, et al. Laforin, the most
common protein mutated in Lafora disease, regulates
autophagy. Hum Mol Genet 2010;19:2867–76.
Article  CAS  Google Scholar 
60. Criado O, Aguado C, Gayarre J, et al. Lafora bodies and
neurological defects in malin-deficient mice correlate with
impaired autophagy. Hum Mol Genet 2012;21:1521–33.
Article  CAS  Google Scholar 
61. Rao SN, Maity R, Sharma J, et al. Sequestration of chaperones
and proteasome into Lafora bodies and proteasomal
dysfunction induced by Lafora disease-associated mutations of
malin. Hum Mol Genet 2010;19:4726–34.
Article  CAS  Google Scholar 
62. Alexander WS . Progressive fibrinoid degeneration of


fibrillary astrocytes associated with mental retardation in a
hydrocephalic infant. Brain 1949;72:373–81, 3 pl.
Article  CAS  Google Scholar 
63. Prust M, Wang J, Morizono H, et al. GFAP mutations, age at
onset, and clinical subtypes in Alexander disease. Neurology
2011;77:1287–94.
Article  CAS  Google Scholar 
64. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D,
Goldman JE, Messing A . Mutations in GFAP, encoding glial
fibrillary acidic protein, are associated with Alexander
disease. Nat Genet 2001;27:117–20.
Article  CAS  Google Scholar 
65. Rosenthal W . [On a peculiar swelling of the spinal cord
complicated by syringomyelia.]. Beitr Pathol Anat
1898;23:111–143.
Google Scholar 
66. Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE
. Alexander disease. J Neurosci 2012;32:5017–23.
Article  CAS  Google Scholar 
67. Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE,
Brenner M . Fatal encephalopathy with astrocyte inclusions in
GFAP transgenic mice. Am J Pathol 1998;152:391–8.
CAS  PubMed  PubMed Central  Google Scholar 
68. Hagemann TL, Connor JX, Messing A . Alexander disease-
associated glial fibrillary acidic protein mutations in mice
induce Rosenthal fiber formation and a white matter stress
response. J Neurosci 2006;26:11162–73.
Article  CAS  Google Scholar 


69. Liem RK, Messing A . Dysfunctions of neuronal and glial
intermediate filaments in disease. J Clin Invest
2009;119:1814–24.
Article  CAS  Google Scholar 
70. Tang G, Perng MD, Wilk S, Quinlan R, Goldman JE .
Oligomers of mutant glial fibrillary acidic protein (GFAP)
Inhibit the proteasome system in alexander disease astrocytes,
and the small heat shock protein alphaB-crystallin reverses
the inhibition. J Biol Chem 2010;285:10527–37.
Article  CAS  Google Scholar 
71. Perng MD, Wen SF, Gibbon T, et al. Glial fibrillary acidic
protein filaments can tolerate the incorporation of assembly-
compromised GFAP-delta, but with consequences for filament
organization and alphaB-crystallin association. Mol Biol Cell
2008;19:4521–33.
Article  CAS  Google Scholar 
72. Hagemann TL, Boelens WC, Wawrousek EF, Messing A .
Suppression of GFAP toxicity by alphaB-crystallin in mouse
models of Alexander disease. Hum Mol Genet 2009;18:1190–9.
Article  CAS  Google Scholar 
73. Tang G, Xu Z, Goldman JE . Synergistic effects of the SAPK/
JNK and the proteasome pathway on glial fibrillary acidic
protein (GFAP) accumulation in Alexander disease. J Biol
Chem 2006;281:38634–43.
Article  CAS  Google Scholar 
74. Tang G, Yue Z, Talloczy Z, et al. Autophagy induced by
Alexander disease-mutant GFAP accumulation is regulated by
p38/MAPK and mTOR signaling pathways. Hum Mol Genet
2008;17:1540–55.
Article  CAS  Google Scholar 


75. Pandey UB, Nie Z, Batlevi Y, et al. HDAC6 rescues
neurodegeneration and provides an essential link between
autophagy and the UPS. Nature 2007;447:859–63.
Article  CAS  Google Scholar 
76. Iwata A, Riley BE, Johnston JA, Kopito RR . HDAC6 and
microtubules are required for autophagic degradation of
aggregated huntingtin. J Biol Chem 2005;280:40282–92.
Article  CAS  Google Scholar 
77. Ding WX, Ni HM, Gao W, et al. Linking of autophagy to
ubiquitin-proteasome system is important for the regulation
of endoplasmic reticulum stress and cell viability. Am J Pathol
2007;171:513–24.
Article  CAS  Google Scholar 
78. Rubinsztein DC, Codogno P, Levine B . Autophagy modulation
as a potential therapeutic target for diverse diseases. Nat Rev
Drug Discov 2012;11:709–30.
Article  CAS  Google Scholar 
79. Harris H, Rubinsztein DC . Control of autophagy as a therapy
for neurodegenerative disease. Nat Rev Neurol 2012;8:108–17.
Article  CAS  Google Scholar 
Download references
Author information
Author notes
1. The first two authors contributed equally to this work.
Authors and Affiliations


1. Division of Inherited Metabolic Diseases, Department of
General Pediatrics, Heidelberg Children’s Hospital, University
Hospital Heidelberg, Ruprecht-Karls-University Heidelberg,
Heidelberg, Germany
Darius Ebrahimi-Fakhari, Lara Wahlster, Georg F.
Hoffmann & Stefan Kölker
2. Institute of Anatomy and Cell Biology, Ruprecht-Karls
University Heidelberg, Heidelberg, Germany
Darius Ebrahimi-Fakhari
3. Institute of Physiology and Pathophysiology, Ruprecht-Karls
University Heidelberg, Heidelberg, Germany
Lara Wahlster
Authors
1. Darius Ebrahimi-Fakhari
View author publications
Search author on:PubMed Google Scholar
2. Lara Wahlster
View author publications
Search author on:PubMed Google Scholar
3. Georg F. Hoffmann
View author publications
Search author on:PubMed Google Scholar
4. Stefan Kölker
View author publications
Search author on:PubMed Google Scholar
Corresponding author


Correspondence to Darius Ebrahimi-Fakhari.
PowerPoint slides
PowerPoint slide for Fig. 1
PowerPoint slide for Fig. 2
PowerPoint slide for Fig. 3
PowerPoint slide for Fig. 4
PowerPoint slide for Fig. 5
PowerPoint slide for Fig. 6
PowerPoint slide for Fig. 7
Rights and permissions
Reprints and permissions
About this article
Cite this article
Ebrahimi-Fakhari, D., Wahlster, L., Hoffmann, G. et al. Emerging
role of autophagy in pediatric neurodegenerative and
neurometabolic diseases. Pediatr Res 75, 217–226 (2014). https://
doi.org/10.1038/pr.2013.185
Download citation
•  Received: 20 March 2013


•  Accepted: 24 June 2013
•  Published: 28 October 2013
•  Issue date: January 2014
•  DOI: https://doi.org/10.1038/pr.2013.185
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
•  Aggregation-prone GFAP mutation in Alexander
disease validated using a zebrafish model
○  So-Hyun Lee
○  Tai-Seung Nam
○  Seok-Yong Choi
BMC Neurology (2017)
•  Activation of the AMPK-ULK1 pathway plays an
important role in autophagy during prion
infection
○  Xue-Yu Fan
○  Chan Tian


○  Xiao-Ping Dong
Scientific Reports (2015)
•  The Parkinsonian mimetic, 6-OHDA, impairs
axonal transport in dopaminergic axons
○  Xi Lu
○  Jeong Sook Kim-Han
○  Karen L O'Malley
Molecular Neurodegeneration (2014)
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Podcasts
•  Videos
•  Current issue
•  Collections
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Journal Information


•  About the Editors
•  Contact
•  About the Partners
•  For Advertisers
•  Subscribe
•  Announcements
Publish with us
•  For Authors & Referees
•  Language editing services
•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Pediatric Research (Pediatr Res)
ISSN 1530-0447 (online)
ISSN 0031-3998 (print)
nature.com sitemap


About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services


•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


